Skip to main content
Top

Cardiovascular Drugs and Therapy

Issue 6/2023

Content (18 Articles)

Editorial

Who Should Be the Corresponding Author, What Are Their Responsibilities, and What Email Address Should They Provide?

Yochai Birnbaum, Masafumi Kitakaze, David Grieve, Barry F. Uretsky

CircCHMP5 Contributes to Ox-LDL-induced Endothelial Cell Injury Through the Regulation of MiR-532-5p/ROCK2 axis

Xia Li, Xiaoli Kang, Yali Di, Shuxian Sun, Liming Yang, Bin Wang, Zheng Ji

Depletion of microRNA-92a Enhances the Role of Sevoflurane Treatment in Reducing Myocardial Ischemia–Reperfusion Injury by Upregulating KLF4

Qianfu Wu, Haihui Wang, Fei He, Jiali Zheng, Hongjing Zhang, Chang Cheng, Panwei Hu, Rong Lu, Guoliang Yan

Oral Anticoagulant Original Article

Non-VKA Oral Anticoagulants in Adult Congenital Heart Disease: a Single-Center Study

Pedro Garcia Brás, Tânia Branco Mano, Tiago Rito, Alexandra Castelo, Vera Ferreira, Ana Agapito, Rui Cruz Ferreira, Fatima Pinto, Lídia de Sousa

Disulfiram protects against abdominal aortic aneurysm by ameliorating vascular smooth muscle cells pyroptosis

Fei Liao, Ling Wang, Zhinan Wu, Guqing Luo, Yuxuan Qian, Xinjie He, Song Ding, Jun Pu

Obesity Orginal Article

Bicyclol Attenuates Obesity-Induced Cardiomyopathy via Inhibiting NF-κB and MAPK Signaling Pathways

Yanghao Chen, Wante Lin, Lingfeng Zhong, Zimin Fang, Bozhi Ye, Zhe Wang, Nipon Chattipakorn, Weijian Huang, Guang Liang, Gaojun Wu

A Clinical Perspective on Arsenic Exposure and Development of Atherosclerotic Cardiovascular Disease

Gurleen Kaur, Karan P. Desai, Isabella Y. Chang, Jonathan D. Newman, Roy O. Mathew, Sripal Bangalore, Ferdinand J. Venditti, Mandeep S. Sidhu

Erythropoietin Review Article

Role of Erythropoiesis-Stimulating Agents in Cardiovascular Protection in CKD Patients: Reappraisal of Their Impact and Mechanisms

Tetsuji Miura, Tatsuya Sato, Toshiyuki Yano, Akira Takaguri, Takayuki Miki, Noritsugu Tohse, Keitaro Nishizawa

Dabigatran Review Article

Efficacy and Safety of Direct Oral Anticoagulants (DOACs) Versus Warfarin in Atrial Fibrillation Patients with Prior Stroke: a Systematic Review and Meta-analysis

Kandavadivu Umashankar, Marco Mammi, Ebtissam Badawoud, Yuzhi Tang, Mengqi Zhou, Jorge C. Borges, Aaron Liew, Mattia Migliore, Rania A. Mekary

Open Access Aortic Valve Replacement Short Communication

Rivaroxaban After Transcatheter Aortic Valve Replacement: A Critical Appraisal of the GALILEO Trial

Patrick Sulzgruber, Andreas Hammer, Alexander Niessner

Open Access Heart Failure Trial Designs

The HF-AF ENERGY Trial: Nicotinamide Riboside for the Treatment of Atrial Fibrillation in Heart Failure Patients

Lisa Pool, Paul Knops, Olivier C. Manintveld, Jasper J. Brugts, Dominic A. M. J. Theuns, Bianca J. J. M. Brundel, Natasja M. S. de Groot